Tamboboy, Maria Teresa C.

HRN: 15-80-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM (VIAL)
11/27/2022
12/01/2022
IVT
2g
2g Now Then Q6
PROM X 30 Hours
Waiting Final Action 
11/29/2022
CO-AMOXICLAV 625MG (TAB)
11/29/2022
12/06/2022
PO
625mg
BID X 7 Days
Post Partum; PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: